Research Directory

Multiple ways to genetically alter T cells

Read more

The sky is the limit as Celgene invests in Juno

Read more

Assessing regulatory T cells as therapy

Read more

Engineered cell therapies - the cutting edge

Read more

New agents fight B-cell malignancies

Read more

Gently pushing the accelerator in cancer

Read more

Commentary: Why checkpoint inhibitors need help

Read more

Checkpoint inhibitors - A new horizon for cancer therapy

Read more

Novartis invests in genetically-engineered T cells

Read more